IRIS
MELAIU, OMBRETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.389
AS - Asia 1.534
EU - Europa 1.299
SA - Sud America 265
Continente sconosciuto - Info sul continente non disponibili 241
AF - Africa 34
OC - Oceania 2
Totale 6.764
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.286
SG - Singapore 648
IT - Italia 588
CN - Cina 231
BR - Brasile 222
HK - Hong Kong 204
RU - Federazione Russa 186
VN - Vietnam 142
IE - Irlanda 119
BD - Bangladesh 98
JP - Giappone 76
DE - Germania 75
FI - Finlandia 74
NL - Olanda 69
GB - Regno Unito 66
CA - Canada 49
FR - Francia 33
IN - India 32
ID - Indonesia 20
AT - Austria 16
ES - Italia 16
MX - Messico 15
SE - Svezia 15
AR - Argentina 14
IQ - Iraq 11
PL - Polonia 11
TR - Turchia 11
EC - Ecuador 10
ZA - Sudafrica 8
CO - Colombia 7
JM - Giamaica 7
MA - Marocco 7
MY - Malesia 7
TH - Thailandia 7
HN - Honduras 6
KR - Corea 6
NG - Nigeria 6
PH - Filippine 6
CR - Costa Rica 5
NI - Nicaragua 5
UA - Ucraina 5
UZ - Uzbekistan 5
AL - Albania 4
CL - Cile 4
CZ - Repubblica Ceca 4
PK - Pakistan 4
DZ - Algeria 3
GT - Guatemala 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
VE - Venezuela 3
AU - Australia 2
BB - Barbados 2
BS - Bahamas 2
BZ - Belize 2
EG - Egitto 2
GI - Gibilterra 2
IR - Iran 2
KW - Kuwait 2
LT - Lituania 2
LV - Lettonia 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
TN - Tunisia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 6.525
Salva come PNG Salva come JPEG
Città #
Singapore 383
San Jose 377
Ashburn 220
Hong Kong 202
Rome 189
Chandler 146
Council Bluffs 145
Dublin 119
New York 106
Beijing 87
Los Angeles 86
Tokyo 71
Santa Clara 67
The Dalles 60
Wilmington 57
Atlanta 52
Waller 47
Buffalo 46
Chicago 45
Helsinki 40
Ho Chi Minh City 37
Milan 37
Hanoi 36
Hickman 36
Fairfield 34
Savannah 34
Stone Mountain 34
Burbank 32
São Paulo 31
Denver 28
Lappeenranta 28
Moscow 28
Phoenix 27
Ann Arbor 26
Houston 26
Morton Grove 24
Dallas 23
Brooklyn 19
Salt Lake City 19
Colorado Springs 18
Frankfurt am Main 18
London 18
Munich 17
Indianapolis 16
Medford 16
Minneapolis 16
Elk Grove Village 14
Benton Harbor 13
Seattle 13
Baton Rouge 12
Forney 12
Genoa 12
Jakarta 12
Johnson City 12
Lauterbourg 12
Montreal 12
Browns Mills 11
Naples 11
Woodbridge 11
Da Nang 10
Miami 10
Nuremberg 10
Orem 10
Tampa 10
Toronto 10
Vienna 10
Würzburg 10
Amsterdam 9
Redondo Beach 9
San Diego 9
Cambridge 8
Lawrence 8
Bangkok 7
Boardman 7
Boston 7
Chennai 7
Lancaster 7
McDonough 7
Mülheim 7
Philadelphia 7
Turin 7
Warsaw 7
Belo Horizonte 6
Cincinnati 6
Des Moines 6
Engelhard 6
Haiphong 6
Lagos 6
Manchester 6
Monte Vista 6
Newark 6
North Bergen 6
Rio de Janeiro 6
Seoul 6
Bologna 5
Charlotte 5
Columbus 5
Guangzhou 5
Hounslow 5
Kingston 5
Totale 3.675
Salva come PNG Salva come JPEG
Nome #
Identification of overexpressed genes in malignant pleural mesothelioma 482
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy 192
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of beta TrCP 190
Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors 188
The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival 165
Autophagy inhibition enhances T and NK immunogenicity in neuroblastoma 156
ERAP1 controls the interaction of the inhibitory receptor KIR3DL1 with HLA-B51:01 by affecting natural killer cell function 154
Quantification of the immune content in neuroblastoma: Deep learning and topological data analysis in digital pathology 149
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma 148
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies 129
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma 123
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma 123
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma 119
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma 116
News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors 114
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 108
The genetic susceptibility in the development of malignant pleural mesothelioma 107
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing 106
Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma 103
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion 101
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma 99
Neoadjuvant Treatment as a Risk Factor for Variation of Upper Limb Lymph Node Drainage During Axillary Reverse Mapping in Breast Cancer: A Prospective Observational Study 99
Immunogenic cell death inducers in cancer immunotherapy to turn cold tumors into hot tumors 98
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 96
Dendritic cells: Behind the scenes of t-cell infiltration into the tumor microenvironment 96
The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview 94
MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma 92
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview 91
Counter-regulation of regulatory T cells by autoreactive CD8 + T cells in rheumatoid arthritis 89
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma 89
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors 89
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 88
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma 87
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy 86
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 86
Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy. 86
Eif4g1 and ran as possible drivers for malignant pleural mesothelioma 86
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 85
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival 84
ERAP1 and ERAP2 enzymes: A protective shield for ras against COVID-19? 81
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 81
A Novel Panel of Serum Biomarkers for MPM Diagnosis 80
A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors 80
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors 80
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 79
Characterization of novel 3′untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide 75
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 74
Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis 72
Expression status of candidate genes in mesothelioma tissues and cell lines 71
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma 71
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes 68
Impact of natural occurring erap1 single nucleotide polymorphisms within mirna-binding sites on hcmv infection 67
A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays 67
Role of genetic variations on MHC class I antigen-processing genes in human cancer and viral-mediated diseases 65
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity 65
Clinical Feature Ranking Based on Ensemble Machine Learning Reveals Top Survival Factors for Glioblastoma Multiforme 64
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (PLoS ONE (2017) 12:6 (e0180317) DOI: 10.1371/journal.pone.0085935) 64
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 62
Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors 61
Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24 61
The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy 60
Correction: Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma 57
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 56
Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma 53
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade 53
The regulatory roles of phosphatases in cancer 49
Editorial: Community series in cell network in antitumor immunity of pediatric and adult solid tumors, volume II 46
Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation 34
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer 31
Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas 24
Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cells 20
Totale 6.764
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.386
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202253 0 0 0 0 0 9 5 3 6 3 4 23
2022/2023503 8 7 44 48 52 118 60 28 56 15 57 10
2023/2024247 27 16 20 6 35 62 12 7 12 19 4 27
2024/20251.410 21 214 133 103 45 199 84 43 87 93 282 106
2025/20262.856 217 117 222 186 253 92 471 284 341 245 224 204
2026/20271.504 628 170 535 171 0 0 0 0 0 0 0 0
Totale 6.764